Modified neonatal B-cell repertoire as a consequence of rituximab administration to a pregnant woman

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Rheumatology (Oxford, England) England), 2013-02, Vol.52 (2), p.405-406
Hauptverfasser: Martínez-Martínez, Marco U, Baranda-Cándido, Lourdes, González-Amaro, Roberto, Pérez-Ramírez, Oscar, Abud-Mendoza, Carlos
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 406
container_issue 2
container_start_page 405
container_title Rheumatology (Oxford, England)
container_volume 52
creator Martínez-Martínez, Marco U
Baranda-Cándido, Lourdes
González-Amaro, Roberto
Pérez-Ramírez, Oscar
Abud-Mendoza, Carlos
description
doi_str_mv 10.1093/rheumatology/kes164
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_rheumatology_kes164</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>22772325</sourcerecordid><originalsourceid>FETCH-LOGICAL-c317t-3453f05e4f28e4fb976098ad3652784a4bd68a3dffa46f387e7c81f27a5464d43</originalsourceid><addsrcrecordid>eNpNkMtOwzAQRS0EoqXwBUjIPxDq2E6cLqHiJRWxgXU0icfFkNjBdgX9e4IKFZuZWcy5ujqEnOfsMmcLMQ-vuOkh-c6vt_N3jHkpD8g0lyXPmBD8cH9zOSEnMb4xxopcVMdkwrlSXPBiSvSj19ZY1NShd5Cgo9dZi11HAw4YkrcBKUQKtPUu4scGXYvUGxps2nzZHhoKurfOxhQgWe9o8uPzEHDtwCX66Xtwp-TIQBfx7HfPyMvtzfPyPls93T0sr1ZZK3KVMiELYViB0vBqHM1ClWxRgRZlwVUlQTa6rEBoY0CWRlQKVVvlhisoZCm1FDMidrlt8DEGNPUQxophW-es_nFW_3dW75yN1MWOGjZNj3rP_EkS39Drbo4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Modified neonatal B-cell repertoire as a consequence of rituximab administration to a pregnant woman</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Martínez-Martínez, Marco U ; Baranda-Cándido, Lourdes ; González-Amaro, Roberto ; Pérez-Ramírez, Oscar ; Abud-Mendoza, Carlos</creator><creatorcontrib>Martínez-Martínez, Marco U ; Baranda-Cándido, Lourdes ; González-Amaro, Roberto ; Pérez-Ramírez, Oscar ; Abud-Mendoza, Carlos</creatorcontrib><identifier>ISSN: 1462-0324</identifier><identifier>EISSN: 1462-0332</identifier><identifier>DOI: 10.1093/rheumatology/kes164</identifier><identifier>PMID: 22772325</identifier><language>eng</language><publisher>England</publisher><subject>Adult ; Antibodies, Monoclonal, Murine-Derived - therapeutic use ; Antigens, CD19 - metabolism ; B-Lymphocyte Subsets - drug effects ; B-Lymphocyte Subsets - immunology ; CD79 Antigens - metabolism ; Cell Count ; Female ; Flow Cytometry ; Humans ; Immunologic Factors - therapeutic use ; Infant, Newborn ; Maternal-Fetal Exchange ; Pregnancy ; Pregnancy Complications, Hematologic ; Purpura, Thrombocytopenic, Idiopathic - drug therapy ; Rituximab ; Young Adult</subject><ispartof>Rheumatology (Oxford, England), 2013-02, Vol.52 (2), p.405-406</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c317t-3453f05e4f28e4fb976098ad3652784a4bd68a3dffa46f387e7c81f27a5464d43</citedby><cites>FETCH-LOGICAL-c317t-3453f05e4f28e4fb976098ad3652784a4bd68a3dffa46f387e7c81f27a5464d43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22772325$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Martínez-Martínez, Marco U</creatorcontrib><creatorcontrib>Baranda-Cándido, Lourdes</creatorcontrib><creatorcontrib>González-Amaro, Roberto</creatorcontrib><creatorcontrib>Pérez-Ramírez, Oscar</creatorcontrib><creatorcontrib>Abud-Mendoza, Carlos</creatorcontrib><title>Modified neonatal B-cell repertoire as a consequence of rituximab administration to a pregnant woman</title><title>Rheumatology (Oxford, England)</title><addtitle>Rheumatology (Oxford)</addtitle><subject>Adult</subject><subject>Antibodies, Monoclonal, Murine-Derived - therapeutic use</subject><subject>Antigens, CD19 - metabolism</subject><subject>B-Lymphocyte Subsets - drug effects</subject><subject>B-Lymphocyte Subsets - immunology</subject><subject>CD79 Antigens - metabolism</subject><subject>Cell Count</subject><subject>Female</subject><subject>Flow Cytometry</subject><subject>Humans</subject><subject>Immunologic Factors - therapeutic use</subject><subject>Infant, Newborn</subject><subject>Maternal-Fetal Exchange</subject><subject>Pregnancy</subject><subject>Pregnancy Complications, Hematologic</subject><subject>Purpura, Thrombocytopenic, Idiopathic - drug therapy</subject><subject>Rituximab</subject><subject>Young Adult</subject><issn>1462-0324</issn><issn>1462-0332</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkMtOwzAQRS0EoqXwBUjIPxDq2E6cLqHiJRWxgXU0icfFkNjBdgX9e4IKFZuZWcy5ujqEnOfsMmcLMQ-vuOkh-c6vt_N3jHkpD8g0lyXPmBD8cH9zOSEnMb4xxopcVMdkwrlSXPBiSvSj19ZY1NShd5Cgo9dZi11HAw4YkrcBKUQKtPUu4scGXYvUGxps2nzZHhoKurfOxhQgWe9o8uPzEHDtwCX66Xtwp-TIQBfx7HfPyMvtzfPyPls93T0sr1ZZK3KVMiELYViB0vBqHM1ClWxRgRZlwVUlQTa6rEBoY0CWRlQKVVvlhisoZCm1FDMidrlt8DEGNPUQxophW-es_nFW_3dW75yN1MWOGjZNj3rP_EkS39Drbo4</recordid><startdate>201302</startdate><enddate>201302</enddate><creator>Martínez-Martínez, Marco U</creator><creator>Baranda-Cándido, Lourdes</creator><creator>González-Amaro, Roberto</creator><creator>Pérez-Ramírez, Oscar</creator><creator>Abud-Mendoza, Carlos</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201302</creationdate><title>Modified neonatal B-cell repertoire as a consequence of rituximab administration to a pregnant woman</title><author>Martínez-Martínez, Marco U ; Baranda-Cándido, Lourdes ; González-Amaro, Roberto ; Pérez-Ramírez, Oscar ; Abud-Mendoza, Carlos</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c317t-3453f05e4f28e4fb976098ad3652784a4bd68a3dffa46f387e7c81f27a5464d43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Antibodies, Monoclonal, Murine-Derived - therapeutic use</topic><topic>Antigens, CD19 - metabolism</topic><topic>B-Lymphocyte Subsets - drug effects</topic><topic>B-Lymphocyte Subsets - immunology</topic><topic>CD79 Antigens - metabolism</topic><topic>Cell Count</topic><topic>Female</topic><topic>Flow Cytometry</topic><topic>Humans</topic><topic>Immunologic Factors - therapeutic use</topic><topic>Infant, Newborn</topic><topic>Maternal-Fetal Exchange</topic><topic>Pregnancy</topic><topic>Pregnancy Complications, Hematologic</topic><topic>Purpura, Thrombocytopenic, Idiopathic - drug therapy</topic><topic>Rituximab</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Martínez-Martínez, Marco U</creatorcontrib><creatorcontrib>Baranda-Cándido, Lourdes</creatorcontrib><creatorcontrib>González-Amaro, Roberto</creatorcontrib><creatorcontrib>Pérez-Ramírez, Oscar</creatorcontrib><creatorcontrib>Abud-Mendoza, Carlos</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Rheumatology (Oxford, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Martínez-Martínez, Marco U</au><au>Baranda-Cándido, Lourdes</au><au>González-Amaro, Roberto</au><au>Pérez-Ramírez, Oscar</au><au>Abud-Mendoza, Carlos</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Modified neonatal B-cell repertoire as a consequence of rituximab administration to a pregnant woman</atitle><jtitle>Rheumatology (Oxford, England)</jtitle><addtitle>Rheumatology (Oxford)</addtitle><date>2013-02</date><risdate>2013</risdate><volume>52</volume><issue>2</issue><spage>405</spage><epage>406</epage><pages>405-406</pages><issn>1462-0324</issn><eissn>1462-0332</eissn><cop>England</cop><pmid>22772325</pmid><doi>10.1093/rheumatology/kes164</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1462-0324
ispartof Rheumatology (Oxford, England), 2013-02, Vol.52 (2), p.405-406
issn 1462-0324
1462-0332
language eng
recordid cdi_crossref_primary_10_1093_rheumatology_kes164
source MEDLINE; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection
subjects Adult
Antibodies, Monoclonal, Murine-Derived - therapeutic use
Antigens, CD19 - metabolism
B-Lymphocyte Subsets - drug effects
B-Lymphocyte Subsets - immunology
CD79 Antigens - metabolism
Cell Count
Female
Flow Cytometry
Humans
Immunologic Factors - therapeutic use
Infant, Newborn
Maternal-Fetal Exchange
Pregnancy
Pregnancy Complications, Hematologic
Purpura, Thrombocytopenic, Idiopathic - drug therapy
Rituximab
Young Adult
title Modified neonatal B-cell repertoire as a consequence of rituximab administration to a pregnant woman
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T02%3A19%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Modified%20neonatal%20B-cell%20repertoire%20as%20a%20consequence%20of%20rituximab%20administration%20to%20a%20pregnant%20woman&rft.jtitle=Rheumatology%20(Oxford,%20England)&rft.au=Mart%C3%ADnez-Mart%C3%ADnez,%20Marco%20U&rft.date=2013-02&rft.volume=52&rft.issue=2&rft.spage=405&rft.epage=406&rft.pages=405-406&rft.issn=1462-0324&rft.eissn=1462-0332&rft_id=info:doi/10.1093/rheumatology/kes164&rft_dat=%3Cpubmed_cross%3E22772325%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/22772325&rfr_iscdi=true